Re: Risk of Recurrent Disease in HER2-Positive Patients
Jean,
I think the neratinib trial is sort of in the same niche as a "herceptin tune up." The concept is to give it to women who have had herceptin and are now NED, to see if it prevents recurrence. I think the feeling is that since Neratinib is an oral med rather than an infusion, it would be easier for the patients.
Becky,
I noticed your new photo too and think you look great!
Hopeful
|